Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VitaStem: Vitamin A and D Prophylaxis in HSCT
NCT06508099Phase 2Recruiting
- Sponsor
- First Saint Petersburg State Medical University
- Start
- May 2024
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin a, vitamin d in graft-versus-host disease (GVHD), sponsored by First Saint Petersburg State Medical University. Started May 2024; status: recruiting.
02
Drugs
vitamin avitamin d
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT06508099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06508099.